These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12430864)

  • 21. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells.
    Seki S; Nakashima H; Nakashima M; Kinoshita M
    Clin Dev Immunol; 2011; 2011():868345. PubMed ID: 22190974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
    Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
    J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells.
    Fujii S; Shimizu K; Steinman RM; Dhodapkar MV
    J Immunol Methods; 2003 Jan; 272(1-2):147-59. PubMed ID: 12505720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.
    Baron JL; Gardiner L; Nishimura S; Shinkai K; Locksley R; Ganem D
    Immunity; 2002 Apr; 16(4):583-94. PubMed ID: 11970881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.
    Yu KO; Im JS; Molano A; Dutronc Y; Illarionov PA; Forestier C; Fujiwara N; Arias I; Miyake S; Yamamura T; Chang YT; Besra GS; Porcelli SA
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3383-8. PubMed ID: 15722411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship studies of novel glycosphingolipids that stimulate natural killer T-cells.
    Tashiro T
    Biosci Biotechnol Biochem; 2012; 76(6):1055-67. PubMed ID: 22790924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical Control of Cytokine Production Using Photoswitchable Galactosylceramides.
    Hartrampf N; Seki T; Baumann A; Watson P; Vepřek NA; Hetzler BE; Hoffmann-Röder A; Tsuji M; Trauner D
    Chemistry; 2020 Apr; 26(20):4476-4479. PubMed ID: 31788876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical and immunological effects of intravenous and intradermal administration of α-galactosylceramide (KRN7000)-pulsed dendritic cells.
    Nicol AJ; Tazbirkova A; Nieda M
    Clin Cancer Res; 2011 Aug; 17(15):5140-51. PubMed ID: 21653690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
    Rogers PR; Matsumoto A; Naidenko O; Kronenberg M; Mikayama T; Kato S
    J Immunol Methods; 2004 Feb; 285(2):197-214. PubMed ID: 14980434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.
    Takahashi T; Nieda M; Koezuka Y; Nicol A; Porcelli SA; Ishikawa Y; Tadokoro K; Hirai H; Juji T
    J Immunol; 2000 May; 164(9):4458-64. PubMed ID: 10779745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
    van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
    Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
    Maeda M; Shadeo A; MacFadyen AM; Takei F
    J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity.
    Lee A; Farrand KJ; Dickgreber N; Hayman CM; Jürs S; Hermans IF; Painter GF
    Carbohydr Res; 2006 Dec; 341(17):2785-98. PubMed ID: 17014832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.